Xingeyuan (Nanjing) Biotechnology Co., Ltd. announced that it will receive CNY 50 million in funding led by Zhongtong Guomai Communication Co., Ltd. on May 6, 2020. The investor will pay the amount in three tranches. The first tranche included a payment of CNY 5 million and it will be paid within five working days, second tranche of CNY 24 million will be completed in next ten working days after the verification of animal disease model, third tranche of CNY 21 million will be completed within ten days after the cell bank construction and production development stage. After this transaction the company will have CNY 1 billion of share capital.